Stay updated on Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-10-04T08:58:09.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.3 to 2.11.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-09-19T22:17:16.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3, indicating a new release.
    Difference
    0.0%
    Check dated 2024-09-04T05:37:32.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-08-14T00:13:45.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The study has expanded to include 176 locations and has been updated from revision v2.9.7 to v2.10.0.
    Difference
    0.2%
    Check dated 2024-07-24T16:17:05.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T09:38:36.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.